Abstract
Hyperimmune activation is a strong predictor of disease progression during pathogenic immunodeficiency virus infections and is mediated in part by sustained type I IFN signaling in response to adventitious microbial infection. The immune inhibitory receptor programmed death-1 (PD-1) regulates functional exhaustion of virus-specific CD8(+) T cells during chronic infections, and in vivo PD-1 blockade has been shown to improve viral control of SIV. Here, we show that PD-1 blockade during chronic SIV infection markedly reduced the expression of transcripts associated with type I IFN signaling in the blood and colorectal tissue of rhesus macaques (RMs). The effect of PD-1 blockade on type I IFN signaling was durable and persisted even under conditions of high viremia. Reduced type I IFN signaling was associated with enhanced expression of some of the junction-associated genes in colorectal tissue and with a profound decrease in plasma LPS levels, suggesting a possible repair of gut-associated junctions and decreased microbial translocation into the blood. PD-1 blockade enhanced immunity to gut-resident pathogenic bacteria, control of gut-associated opportunistic infections, and survival of SIV-infected RMs. Our results suggest PD-1 blockade as a potential novel therapeutic approach to enhance combination antiretroviral therapy by suppressing hyperimmune activation in HIV-infected individuals.
MeSH terms
-
Animals
-
Antibodies, Neutralizing / pharmacology*
-
Antibodies, Neutralizing / therapeutic use
-
Antiviral Agents / pharmacology*
-
Antiviral Agents / therapeutic use
-
Bacteremia / blood
-
Bacteremia / microbiology
-
Bacterial Translocation*
-
Campylobacter / immunology
-
Campylobacter / physiology
-
Chronic Disease
-
Feces / microbiology
-
Feces / parasitology
-
Gene Expression Profiling
-
Humans
-
Interferon Type I / blood
-
Interferon Type I / genetics
-
Interferon Type I / metabolism*
-
Intestinal Mucosa / drug effects
-
Intestinal Mucosa / immunology
-
Intestinal Mucosa / metabolism
-
Intestinal Mucosa / microbiology
-
Intestine, Large / drug effects
-
Intestine, Large / immunology
-
Intestine, Large / metabolism
-
Intestine, Large / microbiology
-
Lipopolysaccharides / blood
-
Macaca mulatta
-
Opportunistic Infections / microbiology
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
-
Programmed Cell Death 1 Receptor / immunology
-
Salmonella / immunology
-
Salmonella / physiology
-
Shigella / immunology
-
Shigella / physiology
-
Signal Transduction
-
Simian Acquired Immunodeficiency Syndrome / drug therapy*
-
Simian Acquired Immunodeficiency Syndrome / immunology
-
Simian Acquired Immunodeficiency Syndrome / metabolism
-
Simian Acquired Immunodeficiency Syndrome / microbiology
-
Simian Immunodeficiency Virus
-
Transcription, Genetic
-
Trichuris / immunology
-
Trichuris / physiology
Substances
-
Antibodies, Neutralizing
-
Antiviral Agents
-
Interferon Type I
-
Lipopolysaccharides
-
Programmed Cell Death 1 Receptor